Marcel Spaargaren

13PUBLICATIONS
48CO-AUTHORS
Molecular targetsHaematological tumoursTumour immunologyTe mātauranga reo Māori (Māori language education)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 11, 2025
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms.

Simon Mobach, Nick D Bergkamp, Ziliang Ma

|Feb 19, 2025
Presentation of CXCL12γ by heparan sulfate proteoglycans activates CXCR4 without desensitization in normal and malignant B cells.

Hildo C Lantermans, Fangxue Ma, Annemieke Kuil

|Mar 07, 2024
The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma.

Hildo C Lantermans, Fangxue Ma, Annemieke Kuil

|Dec 07, 2023
What's brewing for MALT1 in lymphoma?

Marcel Spaargaren

|Aug 17, 2023
The oncogenic human B-cell lymphoma MYD88 L265P mutation genocopies activation by phosphorylation at the Toll/interleukin-1 receptor (TIR) domain.

Marthe Minderman, Hildo Lantermans, Carmen van der Zwaan

|Jun 21, 2023
Endothelial ICAM-1 Adhesome Recruits CD44 for Optimal Transcellular Migration of Human CTLs.

Abraham C I van Steen, Max L B Grönloh, Sander Joosten

Pageof 3

Frequent Collaborators

3 joint publications

Eric Eldering

2 joint publications

Martine J Smit

2 joint publications

Richard J Bende

2 joint publications

Nick D Bergkamp